Quaker Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
969
+12
+1% +$2.58K 0.07% 62
2026
Q1
$208K Sell
957
-26
-3% -$5.77K 0.07% 65
2025
Q4
$225K Sell
983
-19
-2% -$4.33K 0.07% 58
2025
Q3
$232K Buy
1,002
+8
+0.8% +$1.63K 0.08% 60
2025
Q2
$185K Buy
+994
New +$185K 0.06% 69
2024
Q3
$203K Buy
+1,026
New +$191K 0.07% 59

Other funds holding ABBV

Quaker Wealth Management's ABBV Position: Q2 2026 in Review

Quaker Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $2.58K and bringing the position to 969 shares worth $244K. The position accounts for 0.07% of the portfolio, ranked #62.

Quaker Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. 1,432 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Quaker Wealth Management held 969 shares of AbbVie worth $244K as of Q2 2026.
  • Quaker Wealth Management bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.07% of Quaker Wealth Management's portfolio in Q2 2026, its #62 holding.
  • Quaker Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
  • 1,432 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.